Go Back
Applied Therapeutics Inc. reports $10.1 million Q1 loss
By USInMinutes - May 11, 2023, 01:09 PM ET
Last Updated - Jul 18, 2023, 03:30 PM EDT
The company generated $10.70 million in quarterly revenue
Applied Therapeutics Inc. [APLT] has reported fiscal Q1 loss of $10.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.18.
The Pharmaceutical Preparations firm posted revenue of $10.70 million in this period.
Also Read:
- Applied Therapeutics Reports First Quarter 2023 Financial Results
- Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia ...
- Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Applied Therapeutics, Inc. (NASDAQ: APLT)
- Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News